Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Anemia, Diamond-Blackfan | 19 | 2020 | 136 | 3.130 |
Why?
|
Ribosomal Proteins | 14 | 2018 | 360 | 1.350 |
Why?
|
Bone Marrow Diseases | 5 | 2018 | 233 | 1.290 |
Why?
|
Anemia, Aplastic | 7 | 2018 | 228 | 1.260 |
Why?
|
Hemoglobinuria, Paroxysmal | 2 | 2018 | 95 | 1.190 |
Why?
|
Colony-Stimulating Factors | 18 | 1994 | 218 | 1.000 |
Why?
|
Genetic Diseases, Inborn | 2 | 2018 | 601 | 0.890 |
Why?
|
Hematopoietic Stem Cells | 33 | 2019 | 3390 | 0.810 |
Why?
|
Receptors, Granulocyte-Macrophage Colony-Stimulating Factor | 8 | 2005 | 114 | 0.780 |
Why?
|
Interleukin-3 | 18 | 2005 | 429 | 0.760 |
Why?
|
Hematopoiesis | 22 | 2019 | 2063 | 0.730 |
Why?
|
Fanconi Anemia | 7 | 2001 | 324 | 0.670 |
Why?
|
Erythropoiesis | 15 | 2017 | 682 | 0.670 |
Why?
|
Ferredoxin-NADP Reductase | 1 | 2016 | 12 | 0.570 |
Why?
|
Erythrocytes, Abnormal | 1 | 2016 | 121 | 0.540 |
Why?
|
Receptors, Erythropoietin | 5 | 1997 | 144 | 0.530 |
Why?
|
Vitamin B 12 Deficiency | 1 | 2016 | 119 | 0.510 |
Why?
|
Bone Marrow | 15 | 2019 | 2918 | 0.510 |
Why?
|
Mutation | 17 | 2019 | 29877 | 0.450 |
Why?
|
Erythrocyte Transfusion | 1 | 2018 | 564 | 0.440 |
Why?
|
Hematopoietic Cell Growth Factors | 6 | 1993 | 98 | 0.410 |
Why?
|
Granulocyte-Macrophage Colony-Stimulating Factor | 15 | 1998 | 886 | 0.390 |
Why?
|
Bone Marrow Cells | 18 | 2006 | 2424 | 0.350 |
Why?
|
Myelodysplastic Syndromes | 2 | 2018 | 1395 | 0.340 |
Why?
|
Tissue Donors | 3 | 2018 | 2301 | 0.330 |
Why?
|
Antigens, CD34 | 10 | 2019 | 653 | 0.290 |
Why?
|
Growth Substances | 10 | 1994 | 768 | 0.260 |
Why?
|
Granulocytes | 9 | 2019 | 551 | 0.260 |
Why?
|
Erythropoietin | 8 | 2005 | 720 | 0.250 |
Why?
|
Antigens, Surface | 6 | 1986 | 1616 | 0.250 |
Why?
|
Neutrophils | 2 | 2016 | 3767 | 0.250 |
Why?
|
Hematopoietic Stem Cell Transplantation | 5 | 2018 | 5630 | 0.250 |
Why?
|
Recombinant Proteins | 16 | 1997 | 6542 | 0.240 |
Why?
|
Anemia, Sideroblastic | 3 | 2018 | 109 | 0.230 |
Why?
|
Leukemia, Myeloid, Acute | 4 | 2018 | 3605 | 0.220 |
Why?
|
Erythroid Precursor Cells | 5 | 2006 | 211 | 0.210 |
Why?
|
GATA1 Transcription Factor | 3 | 2014 | 296 | 0.210 |
Why?
|
Interleukin-1 | 6 | 1991 | 1251 | 0.200 |
Why?
|
Cells, Cultured | 23 | 2015 | 18968 | 0.190 |
Why?
|
Spherocytosis, Hereditary | 1 | 2021 | 84 | 0.190 |
Why?
|
Recombinant Fusion Proteins | 5 | 1998 | 3732 | 0.190 |
Why?
|
Receptors, Virus | 2 | 2005 | 639 | 0.180 |
Why?
|
Cell Division | 12 | 1999 | 4463 | 0.180 |
Why?
|
Antigens, CD | 6 | 2015 | 4000 | 0.180 |
Why?
|
Gene Expression Regulation | 9 | 2006 | 11908 | 0.180 |
Why?
|
Mutation, Missense | 3 | 2019 | 2559 | 0.170 |
Why?
|
Colony-Forming Units Assay | 13 | 2000 | 351 | 0.170 |
Why?
|
Gene Transfer Techniques | 3 | 2000 | 1204 | 0.170 |
Why?
|
Red-Cell Aplasia, Pure | 1 | 1999 | 27 | 0.170 |
Why?
|
Leucine | 2 | 2020 | 548 | 0.170 |
Why?
|
Chromosomes, Human, Pair 8 | 1 | 2001 | 452 | 0.160 |
Why?
|
Moloney murine leukemia virus | 1 | 1999 | 109 | 0.160 |
Why?
|
Vesicular stomatitis Indiana virus | 1 | 1999 | 92 | 0.160 |
Why?
|
Anemia, Hemolytic, Congenital | 1 | 2019 | 71 | 0.160 |
Why?
|
Spectrin | 1 | 2019 | 170 | 0.160 |
Why?
|
Tyrosine-tRNA Ligase | 1 | 2018 | 10 | 0.160 |
Why?
|
Portraits as Topic | 1 | 2018 | 32 | 0.160 |
Why?
|
RNA Splice Sites | 1 | 2019 | 211 | 0.150 |
Why?
|
Receptors, Interleukin-3 | 1 | 1997 | 29 | 0.150 |
Why?
|
MELAS Syndrome | 1 | 2018 | 56 | 0.150 |
Why?
|
Erythrocyte Membrane | 1 | 2019 | 439 | 0.150 |
Why?
|
Oligonucleotide Array Sequence Analysis | 2 | 2008 | 3774 | 0.150 |
Why?
|
Dexamethasone | 1 | 2005 | 1927 | 0.150 |
Why?
|
Genetic Heterogeneity | 1 | 2001 | 721 | 0.150 |
Why?
|
Receptors, Tumor Necrosis Factor | 1 | 1999 | 584 | 0.140 |
Why?
|
Receptors, Transferrin | 3 | 2015 | 291 | 0.140 |
Why?
|
Acidosis, Lactic | 1 | 2018 | 145 | 0.140 |
Why?
|
Capsid | 1 | 1999 | 434 | 0.140 |
Why?
|
Siblings | 2 | 2018 | 825 | 0.140 |
Why?
|
RNA Interference | 1 | 2005 | 2847 | 0.130 |
Why?
|
Thrombophilia | 1 | 2019 | 307 | 0.130 |
Why?
|
Humans | 105 | 2021 | 759255 | 0.130 |
Why?
|
Receptors, Interleukin | 1 | 1996 | 243 | 0.130 |
Why?
|
Transforming Growth Factor beta1 | 1 | 2019 | 613 | 0.130 |
Why?
|
Viral Envelope Proteins | 1 | 1999 | 638 | 0.130 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 3 | 2009 | 4573 | 0.120 |
Why?
|
Immunologic Deficiency Syndromes | 3 | 2015 | 556 | 0.120 |
Why?
|
RNA, Ribosomal | 2 | 2013 | 226 | 0.120 |
Why?
|
Cell Differentiation | 16 | 2019 | 11476 | 0.120 |
Why?
|
Blood Transfusion | 2 | 2020 | 1327 | 0.120 |
Why?
|
Genetic Diseases, X-Linked | 1 | 2018 | 377 | 0.120 |
Why?
|
RNA Splicing | 1 | 2019 | 915 | 0.120 |
Why?
|
Methionine | 1 | 2016 | 569 | 0.120 |
Why?
|
Purpura, Thrombocytopenic | 1 | 1993 | 41 | 0.110 |
Why?
|
Vitamin B 12 | 1 | 2016 | 522 | 0.110 |
Why?
|
Stem Cell Factor | 3 | 2005 | 198 | 0.110 |
Why?
|
Homocysteine | 1 | 2016 | 640 | 0.110 |
Why?
|
Protein Biosynthesis | 2 | 2014 | 2118 | 0.110 |
Why?
|
RNA, Messenger | 11 | 2014 | 12774 | 0.100 |
Why?
|
Pedigree | 6 | 2015 | 4572 | 0.100 |
Why?
|
Hip Joint | 1 | 2019 | 1006 | 0.100 |
Why?
|
Mitochondrial Proteins | 1 | 2018 | 984 | 0.100 |
Why?
|
Ribosomes | 3 | 2018 | 497 | 0.100 |
Why?
|
Cell Line | 11 | 2008 | 15636 | 0.100 |
Why?
|
Arthroscopy | 1 | 2019 | 960 | 0.100 |
Why?
|
Genetic Linkage | 4 | 2006 | 2381 | 0.100 |
Why?
|
Cell Culture Techniques | 1 | 1999 | 1666 | 0.100 |
Why?
|
Perioperative Care | 1 | 2019 | 1030 | 0.090 |
Why?
|
Cell Cycle | 3 | 1999 | 2939 | 0.090 |
Why?
|
Histocompatibility Antigens Class II | 6 | 1986 | 1446 | 0.090 |
Why?
|
Membrane Glycoproteins | 2 | 1999 | 3730 | 0.090 |
Why?
|
Tumor Suppressor Protein p53 | 2 | 2012 | 2925 | 0.090 |
Why?
|
Receptors, Colony-Stimulating Factor | 4 | 1994 | 50 | 0.090 |
Why?
|
Genes, myb | 1 | 2009 | 18 | 0.090 |
Why?
|
Frameshift Mutation | 1 | 2012 | 386 | 0.090 |
Why?
|
Gene Deletion | 2 | 2018 | 2667 | 0.090 |
Why?
|
Germ-Line Mutation | 1 | 2018 | 1843 | 0.090 |
Why?
|
T-Lymphocytes | 11 | 1999 | 10181 | 0.090 |
Why?
|
Genetic Vectors | 1 | 1999 | 3377 | 0.080 |
Why?
|
Exons | 2 | 2018 | 2389 | 0.080 |
Why?
|
Bone Marrow Transplantation | 8 | 2000 | 2696 | 0.080 |
Why?
|
Molecular Sequence Data | 7 | 2008 | 17629 | 0.080 |
Why?
|
Globins | 3 | 2017 | 403 | 0.080 |
Why?
|
RNA, Small Interfering | 4 | 2013 | 3443 | 0.080 |
Why?
|
Glycoproteins | 3 | 1987 | 2203 | 0.080 |
Why?
|
Transfection | 5 | 1996 | 5783 | 0.080 |
Why?
|
DNA Mutational Analysis | 4 | 2012 | 4111 | 0.080 |
Why?
|
Gene Knockdown Techniques | 2 | 2013 | 1619 | 0.080 |
Why?
|
Drug Discovery | 1 | 2017 | 1054 | 0.080 |
Why?
|
Infant | 14 | 2018 | 35941 | 0.080 |
Why?
|
G1 Phase | 1 | 2009 | 403 | 0.080 |
Why?
|
Base Sequence | 6 | 2012 | 12450 | 0.080 |
Why?
|
Leukemia | 5 | 1997 | 1511 | 0.080 |
Why?
|
Signal Transduction | 6 | 2019 | 23362 | 0.070 |
Why?
|
Fibroblasts | 6 | 2015 | 4084 | 0.070 |
Why?
|
Tumor Necrosis Factor-alpha | 3 | 1988 | 4360 | 0.070 |
Why?
|
Animals | 33 | 2015 | 167838 | 0.070 |
Why?
|
Proto-Oncogene Proteins | 2 | 1996 | 4491 | 0.070 |
Why?
|
Genetic Complementation Test | 2 | 2017 | 555 | 0.070 |
Why?
|
Mice | 18 | 2006 | 81138 | 0.070 |
Why?
|
Thumb | 1 | 2008 | 232 | 0.070 |
Why?
|
Haplotypes | 2 | 2004 | 2762 | 0.070 |
Why?
|
Endothelium, Vascular | 3 | 1988 | 4435 | 0.070 |
Why?
|
Erythroblasts | 3 | 1999 | 143 | 0.070 |
Why?
|
Health Care Surveys | 1 | 2013 | 2433 | 0.070 |
Why?
|
Phosphorylation | 5 | 2019 | 8313 | 0.070 |
Why?
|
Clone Cells | 4 | 1999 | 1663 | 0.060 |
Why?
|
Leukemia, Erythroblastic, Acute | 2 | 1983 | 176 | 0.060 |
Why?
|
Cell Line, Transformed | 2 | 2005 | 871 | 0.060 |
Why?
|
Mesoderm | 1 | 1988 | 672 | 0.060 |
Why?
|
Blotting, Western | 4 | 2012 | 5039 | 0.060 |
Why?
|
Stem Cells | 4 | 2005 | 3525 | 0.060 |
Why?
|
Erythrocytes | 6 | 1987 | 2416 | 0.060 |
Why?
|
Interleukins | 1 | 1990 | 780 | 0.060 |
Why?
|
Granulocyte Colony-Stimulating Factor | 5 | 1997 | 628 | 0.060 |
Why?
|
Cell Proliferation | 4 | 2009 | 10440 | 0.060 |
Why?
|
Abnormalities, Multiple | 1 | 2012 | 1415 | 0.060 |
Why?
|
Retroviridae | 2 | 2005 | 851 | 0.060 |
Why?
|
Macrophages | 5 | 1995 | 5730 | 0.060 |
Why?
|
Endothelium | 1 | 1987 | 764 | 0.060 |
Why?
|
Blotting, Northern | 3 | 2012 | 1544 | 0.060 |
Why?
|
Cell Separation | 8 | 2006 | 1724 | 0.060 |
Why?
|
Immunologic Factors | 1 | 1993 | 1588 | 0.060 |
Why?
|
Fibronectins | 1 | 1987 | 721 | 0.060 |
Why?
|
Cell Lineage | 2 | 2019 | 2524 | 0.050 |
Why?
|
Drug Synergism | 4 | 1994 | 1755 | 0.050 |
Why?
|
Antibodies, Monoclonal | 10 | 1994 | 9194 | 0.050 |
Why?
|
K562 Cells | 1 | 2005 | 641 | 0.050 |
Why?
|
Osteopetrosis | 1 | 1983 | 43 | 0.050 |
Why?
|
RNA | 2 | 2009 | 2723 | 0.050 |
Why?
|
Luciferases | 1 | 2005 | 717 | 0.050 |
Why?
|
Monocytes | 5 | 2019 | 2575 | 0.050 |
Why?
|
Genetic Association Studies | 3 | 2018 | 2712 | 0.050 |
Why?
|
Cleft Palate | 1 | 2008 | 587 | 0.050 |
Why?
|
Polymorphism, Genetic | 3 | 2010 | 4286 | 0.050 |
Why?
|
Male | 29 | 2020 | 358719 | 0.050 |
Why?
|
Introns | 1 | 2005 | 976 | 0.050 |
Why?
|
Flow Cytometry | 6 | 2005 | 5870 | 0.050 |
Why?
|
Chromosomes, Human, 6-12 and X | 1 | 1981 | 77 | 0.050 |
Why?
|
Alternative Splicing | 1 | 2006 | 1091 | 0.050 |
Why?
|
DNA, Complementary | 1 | 2004 | 1993 | 0.050 |
Why?
|
Chromosome Mapping | 3 | 2008 | 4625 | 0.050 |
Why?
|
Sequence Analysis, RNA | 2 | 2019 | 1993 | 0.050 |
Why?
|
Receptors, Cell Surface | 4 | 2000 | 2822 | 0.050 |
Why?
|
Cations | 1 | 2021 | 239 | 0.050 |
Why?
|
Immunosuppressive Agents | 1 | 2013 | 4168 | 0.050 |
Why?
|
Lod Score | 1 | 2001 | 602 | 0.040 |
Why?
|
Cell Membrane | 3 | 1987 | 3683 | 0.040 |
Why?
|
Chromosomes, Human, Pair 19 | 1 | 2001 | 347 | 0.040 |
Why?
|
Dyskeratosis Congenita | 1 | 2000 | 73 | 0.040 |
Why?
|
Membrane Transport Proteins | 1 | 2005 | 1035 | 0.040 |
Why?
|
Killer Cells, Natural | 4 | 1999 | 2198 | 0.040 |
Why?
|
Permeability | 1 | 2021 | 719 | 0.040 |
Why?
|
Mice, Knockout | 3 | 2006 | 14381 | 0.040 |
Why?
|
Reference Values | 1 | 2006 | 4918 | 0.040 |
Why?
|
Cyclophosphamide | 3 | 1997 | 2218 | 0.040 |
Why?
|
Female | 27 | 2020 | 390240 | 0.040 |
Why?
|
Receptors, Tumor Necrosis Factor, Type I | 1 | 1999 | 256 | 0.040 |
Why?
|
Amino Acid Sequence | 5 | 2008 | 13456 | 0.040 |
Why?
|
Liver | 3 | 2009 | 7514 | 0.040 |
Why?
|
Primary Myelofibrosis | 1 | 1980 | 210 | 0.040 |
Why?
|
Pancreatic Diseases | 1 | 2000 | 344 | 0.040 |
Why?
|
Combined Modality Therapy | 2 | 2020 | 8549 | 0.040 |
Why?
|
Case-Control Studies | 4 | 2012 | 21988 | 0.040 |
Why?
|
Macrophage Colony-Stimulating Factor | 2 | 1989 | 186 | 0.040 |
Why?
|
Phenotype | 7 | 2018 | 16532 | 0.040 |
Why?
|
Adolescent | 12 | 2020 | 87560 | 0.040 |
Why?
|
Blood Specimen Collection | 2 | 1997 | 238 | 0.040 |
Why?
|
Receptors, Tumor Necrosis Factor, Type II | 1 | 1999 | 346 | 0.040 |
Why?
|
Down-Regulation | 1 | 2005 | 2920 | 0.040 |
Why?
|
Allyl Compounds | 1 | 2017 | 22 | 0.040 |
Why?
|
Transcription, Genetic | 3 | 2006 | 7595 | 0.040 |
Why?
|
Receptors, Antigen, T-Cell, gamma-delta | 1 | 1999 | 345 | 0.040 |
Why?
|
Heparin, Low-Molecular-Weight | 1 | 2019 | 346 | 0.040 |
Why?
|
Interleukin-2 | 5 | 1996 | 1890 | 0.040 |
Why?
|
Time Factors | 7 | 2005 | 40109 | 0.040 |
Why?
|
Culture Media | 3 | 1989 | 899 | 0.030 |
Why?
|
Thymidine | 1 | 1996 | 300 | 0.030 |
Why?
|
Child, Preschool | 9 | 2020 | 41935 | 0.030 |
Why?
|
HeLa Cells | 2 | 2013 | 3107 | 0.030 |
Why?
|
Janus Kinase 2 | 2 | 1996 | 541 | 0.030 |
Why?
|
Blotting, Southern | 2 | 2000 | 779 | 0.030 |
Why?
|
Janus Kinase 1 | 1 | 1996 | 107 | 0.030 |
Why?
|
Bone Marrow Purging | 2 | 1996 | 108 | 0.030 |
Why?
|
RNA Processing, Post-Transcriptional | 2 | 2010 | 417 | 0.030 |
Why?
|
Blood Component Removal | 1 | 1997 | 132 | 0.030 |
Why?
|
Up-Regulation | 1 | 2005 | 4132 | 0.030 |
Why?
|
Phosphotyrosine | 1 | 1996 | 456 | 0.030 |
Why?
|
Clonal Anergy | 1 | 1996 | 171 | 0.030 |
Why?
|
Adenoviridae | 1 | 2000 | 1084 | 0.030 |
Why?
|
Child | 14 | 2020 | 79623 | 0.030 |
Why?
|
Sequence Homology, Amino Acid | 1 | 2000 | 2755 | 0.030 |
Why?
|
Heterozygote | 2 | 2019 | 2796 | 0.030 |
Why?
|
Cell Cycle Proteins | 2 | 2015 | 3449 | 0.030 |
Why?
|
Stromal Cells | 2 | 1998 | 1327 | 0.030 |
Why?
|
Glucocorticoids | 1 | 2005 | 2142 | 0.030 |
Why?
|
Genes, Tumor Suppressor | 1 | 2000 | 1056 | 0.030 |
Why?
|
Erythroid Cells | 1 | 2017 | 235 | 0.030 |
Why?
|
src Homology Domains | 1 | 1996 | 362 | 0.030 |
Why?
|
Myeloproliferative Disorders | 1 | 1981 | 610 | 0.030 |
Why?
|
Neutropenia | 1 | 2000 | 884 | 0.030 |
Why?
|
Platelet Count | 2 | 1998 | 776 | 0.030 |
Why?
|
Chromosome Aberrations | 1 | 1981 | 1771 | 0.030 |
Why?
|
Genetic Markers | 1 | 2001 | 2608 | 0.030 |
Why?
|
Mice, Inbred NOD | 1 | 1999 | 1836 | 0.030 |
Why?
|
HLA Antigens | 4 | 1986 | 1366 | 0.030 |
Why?
|
Lymphocytes | 7 | 1998 | 2609 | 0.030 |
Why?
|
Nuclear Proteins | 2 | 2000 | 5793 | 0.030 |
Why?
|
Interleukin-11 | 1 | 1994 | 59 | 0.030 |
Why?
|
Syndrome | 1 | 2000 | 3276 | 0.030 |
Why?
|
Mice, Inbred C57BL | 5 | 2015 | 21981 | 0.030 |
Why?
|
Anion Exchange Protein 1, Erythrocyte | 2 | 1986 | 150 | 0.030 |
Why?
|
Isoantigens | 1 | 1996 | 552 | 0.030 |
Why?
|
Mice, SCID | 1 | 1999 | 2628 | 0.030 |
Why?
|
Mice, Inbred DBA | 1 | 1994 | 622 | 0.030 |
Why?
|
Apoptosis | 2 | 2008 | 9492 | 0.030 |
Why?
|
Oxidoreductases | 1 | 2015 | 412 | 0.030 |
Why?
|
Tyrosine | 2 | 1996 | 1440 | 0.030 |
Why?
|
Leukocyte Count | 2 | 1995 | 1599 | 0.030 |
Why?
|
Adult | 17 | 2020 | 219390 | 0.030 |
Why?
|
Aftercare | 1 | 2019 | 919 | 0.030 |
Why?
|
Histocompatibility Antigens Class I | 1 | 1999 | 1354 | 0.030 |
Why?
|
Graft vs Host Disease | 3 | 1996 | 3022 | 0.030 |
Why?
|
Mice, Mutant Strains | 1 | 2015 | 1760 | 0.030 |
Why?
|
DNA | 4 | 2008 | 7237 | 0.030 |
Why?
|
Antilymphocyte Serum | 1 | 2013 | 482 | 0.020 |
Why?
|
Infant, Newborn | 3 | 2000 | 26109 | 0.020 |
Why?
|
Comparative Genomic Hybridization | 1 | 2013 | 473 | 0.020 |
Why?
|
Oncogene Proteins | 1 | 2015 | 721 | 0.020 |
Why?
|
Transforming Growth Factor beta | 1 | 2019 | 1951 | 0.020 |
Why?
|
Genomic Library | 1 | 1991 | 189 | 0.020 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2018 | 1655 | 0.020 |
Why?
|
Endocytosis | 1 | 2015 | 960 | 0.020 |
Why?
|
Young Adult | 4 | 2020 | 58483 | 0.020 |
Why?
|
Gene Expression Regulation, Leukemic | 1 | 1994 | 645 | 0.020 |
Why?
|
Protein Multimerization | 1 | 1996 | 981 | 0.020 |
Why?
|
Lymphoproliferative Disorders | 3 | 1991 | 533 | 0.020 |
Why?
|
Sialoglycoproteins | 2 | 1983 | 315 | 0.020 |
Why?
|
Cyclosporine | 1 | 2013 | 778 | 0.020 |
Why?
|
Blood Proteins | 3 | 1986 | 1163 | 0.020 |
Why?
|
Adaptive Immunity | 1 | 2015 | 724 | 0.020 |
Why?
|
Structure-Activity Relationship | 1 | 1996 | 3087 | 0.020 |
Why?
|
Transplantation, Heterologous | 1 | 1999 | 2377 | 0.020 |
Why?
|
Thrombocytopenia | 1 | 1998 | 1174 | 0.020 |
Why?
|
Fluorescent Antibody Technique | 2 | 1993 | 2474 | 0.020 |
Why?
|
Antigen Presentation | 1 | 1996 | 1254 | 0.020 |
Why?
|
Molecular Weight | 1 | 1993 | 2186 | 0.020 |
Why?
|
Interferon-gamma | 2 | 1990 | 3161 | 0.020 |
Why?
|
Graft Survival | 2 | 1999 | 3789 | 0.020 |
Why?
|
Macromolecular Substances | 1 | 1993 | 1432 | 0.020 |
Why?
|
Sequence Homology, Nucleic Acid | 1 | 1991 | 1055 | 0.020 |
Why?
|
Quinazolines | 1 | 2017 | 1362 | 0.020 |
Why?
|
Protein-Tyrosine Kinases | 2 | 1996 | 2416 | 0.020 |
Why?
|
Trans-Activators | 1 | 2000 | 2860 | 0.020 |
Why?
|
North America | 1 | 2013 | 1282 | 0.020 |
Why?
|
Organ Specificity | 1 | 1994 | 1953 | 0.020 |
Why?
|
Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 1995 | 685 | 0.020 |
Why?
|
Granulomatous Disease, Chronic | 1 | 1990 | 173 | 0.020 |
Why?
|
Leukocytes, Mononuclear | 1 | 1997 | 1827 | 0.020 |
Why?
|
Feasibility Studies | 1 | 2020 | 5194 | 0.020 |
Why?
|
DNA-Binding Proteins | 2 | 1998 | 9590 | 0.020 |
Why?
|
Ribosome Subunits, Large | 1 | 2008 | 4 | 0.020 |
Why?
|
Ribosome Subunits, Small | 1 | 2008 | 5 | 0.020 |
Why?
|
T-Lymphocytes, Cytotoxic | 1 | 1996 | 1765 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 4 | 1998 | 10827 | 0.020 |
Why?
|
Cytoplasm | 1 | 1993 | 1521 | 0.020 |
Why?
|
Phagocytes | 1 | 1990 | 296 | 0.020 |
Why?
|
Cell Survival | 1 | 1999 | 5796 | 0.020 |
Why?
|
Autophagy | 1 | 2017 | 1336 | 0.020 |
Why?
|
Follow-Up Studies | 4 | 2020 | 39216 | 0.020 |
Why?
|
Models, Biological | 1 | 2005 | 9466 | 0.020 |
Why?
|
Immunoconjugates | 1 | 1996 | 947 | 0.020 |
Why?
|
Protein Conformation | 1 | 1996 | 3970 | 0.020 |
Why?
|
Estrogens | 1 | 1995 | 1520 | 0.020 |
Why?
|
Hylobates | 1 | 1987 | 13 | 0.020 |
Why?
|
Lymphoma, Non-Hodgkin | 1 | 1995 | 1376 | 0.020 |
Why?
|
Hematologic Neoplasms | 1 | 2000 | 1898 | 0.020 |
Why?
|
Genetic Testing | 1 | 2001 | 3531 | 0.020 |
Why?
|
Sequence Deletion | 1 | 2012 | 1494 | 0.020 |
Why?
|
Prognosis | 3 | 2020 | 29561 | 0.020 |
Why?
|
Precipitin Tests | 1 | 1988 | 815 | 0.020 |
Why?
|
Hodgkin Disease | 1 | 1995 | 1381 | 0.020 |
Why?
|
Stimulation, Chemical | 1 | 1987 | 306 | 0.020 |
Why?
|
Chromosomes, Human, Pair 3 | 1 | 2008 | 313 | 0.020 |
Why?
|
Pilot Projects | 1 | 2020 | 8540 | 0.020 |
Why?
|
Disease Models, Animal | 1 | 2006 | 18110 | 0.020 |
Why?
|
Chromosomes, Human, Pair 7 | 1 | 1988 | 311 | 0.020 |
Why?
|
Receptors, Estrogen | 1 | 1995 | 2201 | 0.020 |
Why?
|
Polymerase Chain Reaction | 2 | 1995 | 6070 | 0.020 |
Why?
|
Protein Processing, Post-Translational | 1 | 1994 | 1972 | 0.020 |
Why?
|
RNA, Ribosomal, 18S | 1 | 2006 | 57 | 0.020 |
Why?
|
Chromosomes, Human, Pair 5 | 1 | 1988 | 385 | 0.020 |
Why?
|
Chromosomes, Human, Pair 17 | 1 | 1988 | 419 | 0.020 |
Why?
|
Nucleoside Transport Proteins | 1 | 1986 | 8 | 0.020 |
Why?
|
Umbilical Veins | 1 | 1987 | 426 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-myb | 1 | 2006 | 76 | 0.020 |
Why?
|
Point Mutation | 2 | 2005 | 1594 | 0.020 |
Why?
|
Cell Aggregation | 1 | 1986 | 239 | 0.020 |
Why?
|
Anemia | 1 | 2015 | 1509 | 0.020 |
Why?
|
Proteins | 2 | 1998 | 6029 | 0.020 |
Why?
|
DNA, Neoplasm | 1 | 1991 | 1744 | 0.020 |
Why?
|
Herpesvirus 4, Human | 2 | 1981 | 1072 | 0.020 |
Why?
|
Venous Thromboembolism | 1 | 2019 | 1849 | 0.020 |
Why?
|
Hematologic Diseases | 1 | 1990 | 497 | 0.020 |
Why?
|
Giant Cell Tumors | 1 | 1986 | 90 | 0.020 |
Why?
|
Immunologic Techniques | 1 | 1986 | 213 | 0.020 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 1996 | 2896 | 0.020 |
Why?
|
Molecular Structure | 1 | 1990 | 1895 | 0.020 |
Why?
|
Lymphocyte Activation | 1 | 1996 | 5497 | 0.020 |
Why?
|
Receptors, Immunologic | 1 | 1991 | 1434 | 0.020 |
Why?
|
Induced Pluripotent Stem Cells | 1 | 2017 | 1845 | 0.020 |
Why?
|
Lymphocyte Function-Associated Antigen-1 | 1 | 1986 | 377 | 0.020 |
Why?
|
Cytokines | 1 | 2000 | 7346 | 0.020 |
Why?
|
Cricetulus | 1 | 1986 | 815 | 0.010 |
Why?
|
DNA Copy Number Variations | 1 | 2013 | 2012 | 0.010 |
Why?
|
Blood Group Antigens | 1 | 1986 | 187 | 0.010 |
Why?
|
Protein Binding | 1 | 1996 | 9334 | 0.010 |
Why?
|
Antigens, Differentiation, T-Lymphocyte | 1 | 1986 | 900 | 0.010 |
Why?
|
Antigen-Presenting Cells | 1 | 1987 | 967 | 0.010 |
Why?
|
Kinetics | 1 | 1991 | 6380 | 0.010 |
Why?
|
Heme | 1 | 2005 | 313 | 0.010 |
Why?
|
Chromosome Deletion | 1 | 2008 | 1387 | 0.010 |
Why?
|
Anticoagulants | 1 | 2019 | 4897 | 0.010 |
Why?
|
Microarray Analysis | 1 | 2006 | 748 | 0.010 |
Why?
|
Chromosomes, Human, Pair 1 | 1 | 2005 | 635 | 0.010 |
Why?
|
3' Untranslated Regions | 1 | 2005 | 522 | 0.010 |
Why?
|
I Blood-Group System | 1 | 1982 | 8 | 0.010 |
Why?
|
Cyclosporins | 1 | 1983 | 216 | 0.010 |
Why?
|
Genes | 1 | 1987 | 1845 | 0.010 |
Why?
|
Blood Grouping and Crossmatching | 1 | 1983 | 100 | 0.010 |
Why?
|
Receptors, Fc | 2 | 1989 | 534 | 0.010 |
Why?
|
Cricetinae | 1 | 1986 | 2427 | 0.010 |
Why?
|
Neoplasm Proteins | 1 | 1994 | 3613 | 0.010 |
Why?
|
X Chromosome | 3 | 1995 | 815 | 0.010 |
Why?
|
B-Lymphocytes | 1 | 2015 | 4733 | 0.010 |
Why?
|
Placenta | 1 | 1991 | 1699 | 0.010 |
Why?
|
Tumor Virus Infections | 2 | 1981 | 438 | 0.010 |
Why?
|
Middle Aged | 8 | 2020 | 219653 | 0.010 |
Why?
|
Cloning, Molecular | 1 | 1987 | 4171 | 0.010 |
Why?
|
Cohort Studies | 2 | 2018 | 41247 | 0.010 |
Why?
|
Protein Subunits | 1 | 2005 | 943 | 0.010 |
Why?
|
Antigen-Antibody Complex | 1 | 1983 | 513 | 0.010 |
Why?
|
HLA-DR Antigens | 1 | 1982 | 630 | 0.010 |
Why?
|
Lipopolysaccharides | 1 | 1988 | 2213 | 0.010 |
Why?
|
Family Health | 1 | 2005 | 1258 | 0.010 |
Why?
|
Forearm | 1 | 1983 | 429 | 0.010 |
Why?
|
Antigens, Differentiation | 2 | 1996 | 913 | 0.010 |
Why?
|
Blood Cell Count | 2 | 1997 | 398 | 0.010 |
Why?
|
Cell Adhesion Molecules | 1 | 1986 | 1600 | 0.010 |
Why?
|
ABO Blood-Group System | 1 | 1982 | 369 | 0.010 |
Why?
|
CREB-Binding Protein | 1 | 2000 | 148 | 0.010 |
Why?
|
Cell Adhesion | 1 | 1986 | 3094 | 0.010 |
Why?
|
Treatment Outcome | 2 | 2019 | 64879 | 0.010 |
Why?
|
Karyotyping | 1 | 1981 | 1177 | 0.010 |
Why?
|
E1A-Associated p300 Protein | 1 | 2000 | 123 | 0.010 |
Why?
|
Inflammation | 1 | 2019 | 10747 | 0.010 |
Why?
|
Rosette Formation | 3 | 1986 | 152 | 0.010 |
Why?
|
Cell Communication | 1 | 1986 | 1641 | 0.010 |
Why?
|
Fanconi Anemia Complementation Group Proteins | 1 | 1998 | 97 | 0.010 |
Why?
|
Immune Sera | 1 | 1998 | 613 | 0.010 |
Why?
|
Cell Transplantation | 1 | 2000 | 473 | 0.010 |
Why?
|
Histocytochemistry | 2 | 1990 | 693 | 0.010 |
Why?
|
Loss of Heterozygosity | 1 | 2000 | 659 | 0.010 |
Why?
|
Mitomycin | 1 | 1998 | 262 | 0.010 |
Why?
|
Epitopes | 2 | 1981 | 2506 | 0.010 |
Why?
|
Neoplasms | 1 | 2006 | 22019 | 0.010 |
Why?
|
Hematocrit | 1 | 1998 | 630 | 0.010 |
Why?
|
Cell Count | 2 | 1995 | 1837 | 0.010 |
Why?
|
GRB2 Adaptor Protein | 1 | 1996 | 101 | 0.010 |
Why?
|
Lymphocyte Culture Test, Mixed | 1 | 1996 | 514 | 0.010 |
Why?
|
Tumor Cells, Cultured | 2 | 1996 | 6131 | 0.010 |
Why?
|
Leukapheresis | 1 | 1995 | 134 | 0.010 |
Why?
|
Swine, Miniature | 1 | 1997 | 959 | 0.010 |
Why?
|
Erythroid-Specific DNA-Binding Factors | 1 | 1995 | 195 | 0.010 |
Why?
|
Immunization | 1 | 1980 | 1228 | 0.010 |
Why?
|
Transcription Factors | 1 | 1995 | 12106 | 0.010 |
Why?
|
Phosphoglycerate Kinase | 1 | 1995 | 67 | 0.010 |
Why?
|
Adenoviruses, Human | 1 | 1996 | 255 | 0.010 |
Why?
|
Phenylalanine | 1 | 1996 | 365 | 0.010 |
Why?
|
Rabbits | 1 | 1981 | 4772 | 0.010 |
Why?
|
Transplantation, Homologous | 1 | 1983 | 4799 | 0.010 |
Why?
|
Coculture Techniques | 1 | 1998 | 1335 | 0.010 |
Why?
|
Spleen | 1 | 2000 | 2297 | 0.010 |
Why?
|
Dosage Compensation, Genetic | 1 | 1995 | 207 | 0.010 |
Why?
|
Glucosephosphate Dehydrogenase | 1 | 1995 | 210 | 0.010 |
Why?
|
Antibodies, Viral | 2 | 1981 | 3143 | 0.010 |
Why?
|
Species Specificity | 1 | 1997 | 2412 | 0.010 |
Why?
|
Chickens | 1 | 1995 | 858 | 0.010 |
Why?
|
Genome, Human | 1 | 2006 | 4412 | 0.010 |
Why?
|
Antigens, Neoplasm | 1 | 1981 | 1997 | 0.010 |
Why?
|
Genes, Reporter | 1 | 1996 | 1532 | 0.010 |
Why?
|
Interleukin-4 | 1 | 1996 | 1132 | 0.010 |
Why?
|
Benzimidazoles | 1 | 1997 | 858 | 0.010 |
Why?
|
Immunoglobulin G | 2 | 1981 | 4546 | 0.010 |
Why?
|
Risk Factors | 1 | 2019 | 74167 | 0.010 |
Why?
|
Radiography | 1 | 1983 | 6964 | 0.010 |
Why?
|
Tretinoin | 1 | 1995 | 522 | 0.010 |
Why?
|
Nitroblue Tetrazolium | 1 | 1990 | 17 | 0.010 |
Why?
|
Macaca mulatta | 1 | 1997 | 2315 | 0.010 |
Why?
|
Mice, Inbred CBA | 1 | 1991 | 436 | 0.010 |
Why?
|
Receptors, Interleukin-1 | 1 | 1991 | 261 | 0.010 |
Why?
|
Drug Administration Schedule | 1 | 1998 | 4898 | 0.010 |
Why?
|
Transplantation, Autologous | 1 | 1995 | 2120 | 0.010 |
Why?
|
Lymphocyte Depletion | 1 | 1991 | 602 | 0.010 |
Why?
|
Fluorescent Dyes | 1 | 1997 | 1914 | 0.010 |
Why?
|
Superoxides | 1 | 1990 | 388 | 0.010 |
Why?
|
Pregnancy | 1 | 1991 | 29658 | 0.010 |
Why?
|
Drug Evaluation | 1 | 1990 | 642 | 0.010 |
Why?
|
Fluorouracil | 1 | 1994 | 1620 | 0.010 |
Why?
|
Membrane Proteins | 1 | 1986 | 7851 | 0.000 |
Why?
|
Receptors, Androgen | 1 | 1995 | 1074 | 0.000 |
Why?
|
Fetus | 2 | 1986 | 1865 | 0.000 |
Why?
|
Nucleic Acid Hybridization | 1 | 1989 | 1304 | 0.000 |
Why?
|
Reproducibility of Results | 1 | 2006 | 20031 | 0.000 |
Why?
|
Tissue and Organ Procurement | 1 | 1996 | 941 | 0.000 |
Why?
|
Swine | 1 | 1997 | 5903 | 0.000 |
Why?
|
Cell Fractionation | 1 | 1987 | 251 | 0.000 |
Why?
|
Immunotherapy | 1 | 1983 | 4622 | 0.000 |
Why?
|
Antibody Formation | 1 | 1991 | 1398 | 0.000 |
Why?
|
Tritium | 1 | 1987 | 707 | 0.000 |
Why?
|
Microscopy, Phase-Contrast | 1 | 1986 | 110 | 0.000 |
Why?
|
Receptors, IgG | 1 | 1989 | 565 | 0.000 |
Why?
|
Cytotoxicity, Immunologic | 1 | 1989 | 1351 | 0.000 |
Why?
|
Infusions, Intravenous | 1 | 1990 | 2235 | 0.000 |
Why?
|
Fetal Hemoglobin | 1 | 1987 | 342 | 0.000 |
Why?
|
Thioguanine | 1 | 1983 | 44 | 0.000 |
Why?
|
Interferon Type I | 1 | 1987 | 557 | 0.000 |
Why?
|
Daunorubicin | 1 | 1983 | 155 | 0.000 |
Why?
|
Photomicrography | 1 | 1981 | 71 | 0.000 |
Why?
|
T-Lymphocytes, Helper-Inducer | 1 | 1987 | 975 | 0.000 |
Why?
|
Aged | 3 | 2005 | 168617 | 0.000 |
Why?
|
Glioblastoma | 1 | 1996 | 3482 | 0.000 |
Why?
|
Infectious Mononucleosis | 1 | 1981 | 133 | 0.000 |
Why?
|
Cytarabine | 1 | 1983 | 696 | 0.000 |
Why?
|
Leukemia, Lymphoid | 1 | 1981 | 309 | 0.000 |
Why?
|
Fetal Blood | 1 | 1987 | 1339 | 0.000 |
Why?
|
Antigens | 1 | 1986 | 1446 | 0.000 |
Why?
|
Agammaglobulinemia | 1 | 1981 | 172 | 0.000 |
Why?
|
Ovarian Neoplasms | 1 | 1996 | 4871 | 0.000 |
Why?
|
Antineoplastic Agents | 1 | 1983 | 13621 | 0.000 |
Why?
|
Immunoglobulin A | 1 | 1981 | 975 | 0.000 |
Why?
|
Interferons | 1 | 1981 | 705 | 0.000 |
Why?
|
Skin | 1 | 1991 | 4467 | 0.000 |
Why?
|
Antigens, Viral | 1 | 1981 | 980 | 0.000 |
Why?
|
Sheep | 1 | 1980 | 1441 | 0.000 |
Why?
|
Immunoglobulin M | 1 | 1981 | 1529 | 0.000 |
Why?
|
Immunity, Cellular | 1 | 1981 | 1558 | 0.000 |
Why?
|
Prostatic Neoplasms | 1 | 1996 | 11324 | 0.000 |
Why?
|
Drug Therapy, Combination | 1 | 1983 | 6496 | 0.000 |
Why?
|
Lung Neoplasms | 1 | 1996 | 13238 | 0.000 |
Why?
|
Immunity, Innate | 1 | 1981 | 3046 | 0.000 |
Why?
|
Breast Neoplasms | 1 | 1996 | 21022 | 0.000 |
Why?
|
Neoplasm Staging | 1 | 1983 | 11123 | 0.000 |
Why?
|
Clinical Trials as Topic | 1 | 1983 | 8055 | 0.000 |
Why?
|
Chronic Disease | 1 | 1981 | 9282 | 0.000 |
Why?
|